ES2060561T1 - Material biologico modificado. - Google Patents

Material biologico modificado.

Info

Publication number
ES2060561T1
ES2060561T1 ES90915320T ES90915320T ES2060561T1 ES 2060561 T1 ES2060561 T1 ES 2060561T1 ES 90915320 T ES90915320 T ES 90915320T ES 90915320 T ES90915320 T ES 90915320T ES 2060561 T1 ES2060561 T1 ES 2060561T1
Authority
ES
Spain
Prior art keywords
species
rejection
biological material
modified biological
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES90915320T
Other languages
English (en)
Other versions
ES2060561T3 (es
Inventor
David James Graham White
Alan Frederick Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imutran Ltd
Original Assignee
Imutran Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26296038&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2060561(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB898922987A external-priority patent/GB8922987D0/en
Priority claimed from GB909017198A external-priority patent/GB9017198D0/en
Application filed by Imutran Ltd filed Critical Imutran Ltd
Publication of ES2060561T1 publication Critical patent/ES2060561T1/es
Application granted granted Critical
Publication of ES2060561T3 publication Critical patent/ES2060561T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/108—Swine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A01K2267/025—Animal producing cells or organs for transplantation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

CONVENCIONALMENTE, EL TEJIDO ANIMAL DE UNA ESPECIE SE PUEDE TRANSPLANTAR SOLAMENTE A OTRA ESPECIE CUANDO LAS ESPECIES SON CONCORDANTES; DE OTRA FORMA OCURRE UN RECHAZO HIPERINMUNE. EN ESTA INVENCION SE MODIFICA EL TEJIDO DEL DONANTE, POR EJEMPLO SIENDO TRANSGENICO, PARA EXPRESAR O ESTAR EN ASOCIACION CON UNA O MAS SUSTANCIAS, LLAMADAS FACTORES DE RESTRICCION COMPLEMENTARIA MONOLOGOS (HCRFS), QUE SON ACTIVOS EN LAS ESPECIES DE RECIPIENTE PARA PREVENIR LA COMPLETA ACTIVACION DEL COMPLEMENTO Y POR LO TANTO EL RECHAZO. LA INVENCION ESTA BASADA EN PARTE EN EL DESCUBRIMIENTO DE QUE EL CAMINO ALTERNATIVO DE ACTIVACION DE COMPLEMENTO, ES RESPONSABLE DEL RECHAZO DE INJERTOS EXTRAÑOS DISCORDANTE, MAS BIEN QUE EL CAMINO CLASICO.
ES90915320T 1989-10-12 1990-10-12 Material biologico modificado. Expired - Lifetime ES2060561T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898922987A GB8922987D0 (en) 1989-10-12 1989-10-12 Modified biological material
GB909017198A GB9017198D0 (en) 1990-08-06 1990-08-06 Modified biological material

Publications (2)

Publication Number Publication Date
ES2060561T1 true ES2060561T1 (es) 1994-12-01
ES2060561T3 ES2060561T3 (es) 1996-08-01

Family

ID=26296038

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90915320T Expired - Lifetime ES2060561T3 (es) 1989-10-12 1990-10-12 Material biologico modificado.

Country Status (27)

Country Link
US (1) US6495735B1 (es)
EP (2) EP0709459A3 (es)
JP (1) JP3302358B2 (es)
KR (2) KR920702410A (es)
CN (2) CN1122719C (es)
AT (1) ATE139562T1 (es)
AU (1) AU654116B2 (es)
BG (1) BG61080B1 (es)
CA (1) CA2067235A1 (es)
CY (1) CY1996A (es)
DE (2) DE69027535T2 (es)
DK (1) DK0495852T3 (es)
ES (1) ES2060561T3 (es)
FI (1) FI921618A (es)
GR (2) GR940300004T1 (es)
HK (1) HK48497A (es)
HU (1) HUT64584A (es)
IE (1) IE75345B1 (es)
IL (2) IL95970A0 (es)
IN (1) IN171948B (es)
MY (1) MY107433A (es)
NO (2) NO303502B1 (es)
NZ (2) NZ248153A (es)
PT (2) PT95580B (es)
RO (1) RO109863B1 (es)
SG (1) SG72614A1 (es)
WO (1) WO1991005855A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705732A (en) * 1989-06-12 1998-01-06 Oklahoma Medical Research Foundation Universal donor cells
EP0483247A4 (en) * 1989-07-21 1992-12-09 Washington University Recombinantly produced human membrane cofactor protein (mcp)
WO1991018097A1 (en) * 1990-05-11 1991-11-28 University Of Melbourne Cd46 variants
US5846715A (en) * 1990-05-11 1998-12-08 The Austin Research Institute CD46 variants
DE69233010T2 (de) * 1991-07-15 2004-02-19 Oklahoma Medical Research Foundation, Oklahoma Universale spenderzellen
US6916654B1 (en) * 1992-06-29 2005-07-12 Oklahoma Medical Research Foundation Universal donor cells
JPH08501451A (ja) * 1992-09-22 1996-02-20 ディーエヌエックス バイオセラピューティックス、インコーポレーテッド 異種移植臓器移植片の事前適応化、その他を目的とする膜間転移によるタンパク質の供給法
US5627264A (en) * 1994-03-03 1997-05-06 Alexion Pharmaceuticals, Inc. Chimeric complement inhibitor proteins
JPH10507906A (ja) * 1994-08-19 1998-08-04 ザ ジェネラル ホスピタル コーポレイション 遺伝子工学処理したブタ細胞
WO1997006241A1 (en) * 1995-08-04 1997-02-20 The General Hospital Corporation Transgenic swine and swine cells having human hla genes
US6166288A (en) * 1995-09-27 2000-12-26 Nextran Inc. Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor
AU1933897A (en) * 1996-03-22 1997-10-17 Imutran Limited Surfaces which prevent or reduce complement activation
EP1676920B1 (en) 1997-03-26 2014-07-09 Imperial Innovations Limited Anticoagulant fusion protein anchored to cell membrane
EP1004238B1 (en) 1997-07-14 2005-12-21 Nippon Meat Packers, Inc. Transgenic pigs
DE69828615T2 (de) * 1997-10-31 2005-12-01 Walter Reed Army Institute Of Research Verwendung von inhibitoren der komplementaktivierung zur herstellung eines medikaments zur inhibierung von nebenwirkungen von pharmazeutischen zusammensetzungen, die amphiphile träger oder wirkstoffträger moleküle enthalten
SE523817C2 (sv) 1999-02-05 2004-05-18 Corline Systems Ab Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler
GB9905503D0 (en) 1999-03-10 1999-05-05 Adprotech Plc Novel compound formulations and methods of delivery
WO2005009134A1 (en) 2003-07-21 2005-02-03 Lifecell Corporation ACELLULAR TISSUE MATRICES MADE FROM GALACTOSE α-1,3-GALACTOSE-DEFICIENT TISSUE
EP2464219B1 (en) 2009-08-14 2019-10-23 Revivicor, Inc. Multi-transgenic pigs for diabetes treatment
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
SG10201506959SA (en) 2010-09-03 2015-10-29 Stemcentrx Inc Novel modulators and methods of use
ES2680636T3 (es) 2011-02-14 2018-09-10 Revivicor Inc. Cerdos genéticamente modificados para xenotrasplante de xenoinjertos vascularizados y derivados de los mismos
AU2014341866B2 (en) 2013-11-04 2018-07-05 Lifecell Corporation Methods of removing alpha-galactose
CN114686427B (zh) * 2022-05-23 2022-07-29 中国人民解放军总医院第一医学中心 一种脾脏调节型b淋巴细胞及其制备方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0081570A4 (en) * 1981-06-12 1985-09-02 Univ Ohio GENETIC TRANSFORMATION OF ZYGOTS.
US4431636A (en) 1982-05-24 1984-02-14 American Cyanamid Company Bis(4-O-polyhexaose-thio)-phenyl ureas and method of use
US5109113A (en) * 1986-05-02 1992-04-28 Genentech, Inc. Membrane anchor fusion polypeptides
JPS62104594A (ja) * 1985-10-31 1987-05-15 Terumo Corp クエン酸塩利用能検査用培地組成物
JPH0742235B2 (ja) * 1985-11-08 1995-05-10 三共株式会社 自己免疫性疾病の予防・治療剤
IL82390A0 (en) * 1986-05-02 1987-10-30 Genentech Inc Nucleic acid and methods for the synthesis of novel daf compositions
GB8615942D0 (en) * 1986-06-30 1986-08-06 Animal & Food Research Council Peptide production
IL89790A (en) * 1988-04-01 2002-05-23 Johns Hopking University Sequences of nucleic acids encoding and cells producing CR1 protein and methods for its production and purification
DE3830271A1 (de) 1988-09-06 1990-03-15 Goetze Otto Mittel mit immunsuppressiver wirkung
US5573940A (en) * 1989-06-12 1996-11-12 Oklahoma Medical Research Foundation Cells expressing high levels of CD59

Also Published As

Publication number Publication date
PT95580A (pt) 1991-09-13
AU6539290A (en) 1991-05-16
FI921618A0 (fi) 1992-04-10
DE69027535T2 (de) 1996-11-28
ATE139562T1 (de) 1996-07-15
PT95580B (pt) 1999-05-31
NZ248153A (en) 1997-07-27
HK48497A (en) 1997-04-25
GR940300004T1 (en) 1994-02-28
NO921438L (no) 1992-04-10
IE903649A1 (en) 1991-04-24
US6495735B1 (en) 2002-12-17
EP0709459A3 (en) 1999-01-07
CA2067235A1 (en) 1991-04-13
PT101896A (pt) 1998-02-27
RO109863B1 (ro) 1995-06-30
JPH05503074A (ja) 1993-05-27
CN1051199A (zh) 1991-05-08
NO303502B1 (no) 1998-07-20
NZ235657A (en) 1994-05-26
CN1491624A (zh) 2004-04-28
MY107433A (en) 1995-12-30
AU654116B2 (en) 1994-10-27
EP0709459A2 (en) 1996-05-01
DK0495852T3 (da) 1996-07-15
KR100317106B1 (ko) 2001-12-22
IL95970A0 (en) 1992-05-25
GR3020741T3 (en) 1996-11-30
BG96329A (bg) 1993-12-24
NO982131L (no) 1992-04-10
KR920702410A (ko) 1992-09-04
EP0495852B1 (en) 1996-06-19
HUT64584A (en) 1994-01-28
HU9201240D0 (en) 1992-06-29
IE75345B1 (en) 1997-08-27
JP3302358B2 (ja) 2002-07-15
DE69027535D1 (de) 1996-07-25
ES2060561T3 (es) 1996-08-01
EP0495852A1 (en) 1992-07-29
BG61080B1 (bg) 1996-10-31
FI921618A (fi) 1992-04-10
NO921438D0 (no) 1992-04-10
CN1122719C (zh) 2003-10-01
IL120795A0 (en) 1997-09-30
CY1996A (en) 1997-09-05
IN171948B (es) 1993-02-13
DE495852T1 (de) 1994-03-31
SG72614A1 (en) 2000-05-23
NO982131D0 (no) 1998-05-11
WO1991005855A1 (en) 1991-05-02
PT101896B (pt) 2003-01-31

Similar Documents

Publication Publication Date Title
ES2060561T1 (es) Material biologico modificado.
ATE176161T1 (de) Knochenersatzmaterial mit fibroblasten-wachstums- faktoren
ES2018769T3 (es) Elemento de anclaje para la retencion de una pieza de articulacion de un dedo o de otra articulacion artificial.
CA2263557A1 (en) Implant consisting of a carrier material containing medical substances and method to produce such an implant
AR018489A1 (es) Uso de una celula realizada geneticamente que comprende dna que codifica una proteina de gen de activacion de linfocito 3 (lag-3) transmembrana y de dicha proteina para la fabricacion de un medicamento util para inducir la proteccion del rechazo de injerto y uso de moleculas antisentido de las misma
BR9007015A (pt) Processo para introducao de dna exogena em celulas de animais de germe e somaticas
ES2110929T3 (es) Suspension de brazo longitudinal.
WO1999053042A3 (en) Biological material with increased expression of endogenous complement regulatory molecules
DK414489D0 (da) Plantevaekstfremmende middel samt fremgangsmaade til fremme af planters vaekst
ES2102397T3 (es) Tratamiento de la enfermedad del ovario policistico.
Sekerková et al. Transplantation of dorsal root ganglion into the olfactory bulb of neonatal rats: a histochemical study
ES2039757T3 (es) Procedimiento para la aceleracion de la maduracion de plantas utiles agricolas.
AN et al. Comparative spermatology of 11 species of Polyplacophora (Mollusca) from the suborders Lepidopleurina, Chitonina
ES2167871T3 (es) Corbata.
FI884041A (fi) Desinfiointikoostumus stafylokokkien tappamiseksi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 495852

Country of ref document: ES